Antonio Dans Selected Research

Stroke (Strokes)

12/2022	Influenza vaccine to reduce adverse vascular events in patients with heart failure: a multinational randomised, double-blind, placebo-controlled trial.
1/2021	Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants.
1/2021	Polypill with or without Aspirin in Persons without Cardiovascular Disease.
1/2020	The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation.
1/2020	Associations of outdoor fine particulate air pollution and cardiovascular disease in 157 436 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.
11/2018	Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study.
12/2011	Dronedarone in high-risk permanent atrial fibrillation.
11/2011	Urinary sodium and potassium excretion and risk of cardiovascular events.
1/2011	The cost implications of the use of telmisartan or ramipril in patients at high risk for vascular events: the ONTARGET study.
9/2010	Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Dans Research Topics

Disease

18	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2011
10	Stroke (Strokes) 12/2022 - 09/2010
7	Heart Failure 12/2022 - 01/2011
4	Myocardial Infarction 12/2022 - 01/2020
3	Vascular Diseases (Vascular Disease) 01/2021 - 01/2011
3	Hemorrhage 01/2021 - 09/2010
3	Atrial Fibrillation 01/2020 - 09/2010
2	Hypertension (High Blood Pressure) 01/2023 - 07/2014
2	Heart Arrest (Cardiac Arrest) 01/2021 - 01/2021
2	Obesity 01/2021 - 01/2020
2	Cognitive Dysfunction 01/2019 - 01/2011
1	Pneumonia (Pneumonitis) 12/2022
1	Human Influenza (Influenza) 12/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2020
1	Rheumatic Heart Disease (Rheumatic Heart Diseases) 01/2020
1	Mitral Valve Stenosis (Mitral Stenosis) 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Disease Progression 01/2020
1	Cataract (Cataracts) 05/2016
1	Neoplasms (Cancer) 05/2016
1	Cardiac Arrhythmias (Arrythmia) 12/2011
1	Diabetes Mellitus 11/2011
1	Glucose Intolerance 09/2011
1	Embolism (Embolus) 09/2010

Drug/Important Bio-Agent (IBA)

5	LipidsIBA 01/2021 - 11/2018
5	Rosuvastatin Calcium (Crestor)FDA Link 01/2021 - 05/2016
5	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2021 - 05/2016
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2019
4	Ramipril (Altace)FDA LinkGeneric 01/2021 - 01/2011
4	Telmisartan (Micardis)FDA Link 01/2020 - 01/2011
4	candesartanIBA 01/2019 - 05/2016
3	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2022 - 01/2019
3	SodiumIBA 01/2020 - 11/2011
3	CholesterolIBA 01/2019 - 05/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 09/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 05/2016
2	PotassiumIBA 11/2018 - 11/2011
1	VaccinesIBA 12/2022
1	Atenolol (Tenormin)FDA LinkGeneric 01/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	Simvastatin (Zocor)FDA LinkGeneric 01/2021
1	Vitamin D FDA LinkGeneric 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	Vitamin K FDA Link 01/2020
1	RivaroxabanIBA 01/2020
1	antineoplaston A10 (A 10)IBA 01/2020
1	Particulate MatterIBA 01/2020
1	AnticoagulantsIBA 01/2019
1	Pantoprazole (Protonix)FDA LinkGeneric 01/2019
1	Proton Pump InhibitorsIBA 01/2019
1	FatsIBA 11/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 05/2016
1	LDL CholesterolIBA 05/2016
1	aliskiren FDA Link 07/2014
1	Antihypertensive Agents (Antihypertensives)IBA 07/2014
1	Dronedarone FDA Link 12/2011
1	Angiotensin Receptor AntagonistsIBA 09/2011
1	Warfarin (Coumadin)FDA LinkGeneric 09/2010
1	Dabigatran FDA Link 09/2010

Therapy/Procedure

3	Therapeutics 01/2021 - 09/2010
1	Secondary Prevention 11/2020
1	Long-Term Care 11/2018